FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/06/2026
Voltar para busca
Dado oficial do USPTO
HIRUNDO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HIRUNDO
ST13
US500000079421230Classe
1, 5, 35, 42, 44
Pedido
79421230
Registro
8182268
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
24/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 35, 42, 44
Data de depósito
02/12/2024
Data de registro
24/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2026
Última transação
24/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
33
Localização do titular
BE
Examinador
SOUDERS, MICHAEL J
Unidade examinadora
M60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
H. B. (pessoa física)
B. P. (pessoa física)
D. V. (pessoa física)
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for industrial purposes and chemical preparations for scientific purposes; chemical reagents for scientific purposes in the field of molecular biology; bacterial preparations other than for medical or veterinary use; enzymes and enzyme preparations for industrial use; chemical preparations for analyses in laboratories for scientific useother than for medical or veterinary purposes; biochemical preparations for scientific purposes; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposesfor use in the research and development and production of drugsmedicinal and pharmaceutical preparations; chemical additives for use in the manufacturing of pharmaceuticals
Classe 5
Pharmaceutical preparations and substances in the field of gynecology and women's healthendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; medicinal preparations for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; medicines for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; biochemical medicines for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; pharmaceutical preparations for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractInflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions for use in the field of gynecology and female health; estrogen preparations for therapeutic purposes; pharmaceutical preparations containing estrogen for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; pharmaceutical preparations for the treatment of female hormonal dysfunction; pharmaceutical preparations for use in hormone replacement therapy; pharmaceutical preparations for the treatment of menopausal symptomsconditions and disorders
Classe 35
Market research and business analysis services; business marketing consulting services in the field of pharmaceuticalbiotechnologybiochemicalmedical device and diagnostics industries; market analysis; providing business information and data processing services in the field of pharmaceuticalbiotechnologybiochemical medical devicediagnostics industries; compilation of statistics for business or commercial purposes in the field of biochemical medical devices
Classe 42
Scientificclinical surgerymedical and life-science research; research and development in the field of biotechnology and biochemistry; research and development in the field of pharmaceuticalsbiopharmaceuticalsmedical devicesmedical diagnostics; research relating to molecular sciences; research and development in the field of drug development; testinganalysisevaluation of pharmaceutical and biochemical productsespecially for use in medicines; research and development of medicines; testing of pharmaceuticals; biotechnology research and development services; product development involving pharmaceutical products; medical and scientific researchconducting clinical trials as part of the research and development of pharmaceuticals and medicines; clinical research in the field of production of chemicals for pharmaceutical usepharmaceuticalsmedical devices and medical diagnostics; scientific researchproviding analysis of statistical data in the field of biotechnology; scientific researchproviding analysis of statistical data in the field of biotechnological diagnostics industries
Classe 44
Medical services; providing medical advice in the field of efficacy of pharmaceuticals; provision of medical data relating to the use of pharmaceuticals; medical information online and on the internet relating to productssolutions and pharmaceutical and medical advances; medical information online and on the internet about productssolutionspharmaceutical or medical advances; providing medical research information in the field of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
24/03/2026
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
27/02/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/01/2026
PUBO
PUBLISHED FOR OPPOSITION
27/01/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/01/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/01/2026
GNFR
FINAL REFUSAL E-MAILED
02/01/2026
CNFR
FINAL REFUSAL WRITTEN
02/01/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/12/2025
RFNT
REFUSAL PROCESSED BY IB
02/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/07/2025
RFRR
REFUSAL PROCESSED BY MPU
14/07/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
30/05/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/05/2025
CNRT
NON-FINAL ACTION WRITTEN
21/05/2025
DOCK
ASSIGNED TO EXAMINER
21/05/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/04/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/04/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HIRUNDO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.